IBC tumor biopsies from most patients expressed clearly detectable levels of PD-1 (18.2% of patients) and PD-L1 (36.4% of patients), as defined by staining scores of 3–4 (moderate to high), and expression levels of this checkpoint receptor/ligand pair were correlated in the TME. Here, PDCD1 is linked to neoplasm.